Article Details

Point Biopharma shares sink 11% on study results; Lilly acquisition still up in air

Retrieved on: 2023-12-18 21:08:38

Tags for this article:

Click the tags to see associated articles and topics

Point Biopharma shares sink 11% on study results; Lilly acquisition still up in air. View article details on HISWAI: https://www.ibj.com/articles/point-biopharma-shares-sink-11-on-study-results-lilly-acquisition-still-up-in-air

Excerpt

Results of a clinical trial for Point Biopharma's lead compound fell short of analysts' expectations, and that development is likely to pressure ...

Article found on: www.ibj.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up